在帕金森病的治疗药物监测
Thomas Müller1, Manfred Gerlach2, Gudrun Hefner3
1Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Gartenstr. 1, 13088, Berlin, Germany.
Journal of neural transmission (Vienna, Austria : 1996)
|September 3, 2024
概括
对帕金森病 (PD) 的治疗药物监测 (TDM) 可以通过测量血药物度来优化利沃多巴治疗. 这种方法有助于管理运动和非运动症状,改善患者在这种渐进的神经疾病的结果.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 帕金森病 (PD) 是一种异质的神经精神疾病,需要为患者量身定制的治疗来管理运动和非运动症状.
- 在PD中神经退行需要多次,个性化调整多巴胺替代药物.
- 勒沃多巴血度的变化受其短半衰期和胃空化的影响,影响治疗疗效.
研究的目的:
- 突出治疗药物监测 (TDM) 在优化帕金森病药物应用方面的潜力.
- 强调血勒沃多巴测定作为PDTDM初步步骤的重要性.
- 通过考虑药物相互作用和药理动力学变异性,探索TDM如何完善治疗策略.
主要方法:
- 建议血测定利沃多巴作为PD中TDM的关键方法.
- 讨论了药物相互作用的影响,患者的遵守,以及同时服用的药物对利沃多巴水平的影响.
- 建议测量其他PD药物 (多巴胺激动剂,阿曼塔丁,COMT/MAO-B抑制剂) 以改善莱沃多巴等效计算.
主要成果:
- 勒沃多巴测量可以提供关于不适当的勒沃多巴反应的见解,可能是由于相互作用或不遵守.
- 了解勒沃多巴和其他PD药物的血度对于有效治疗至关重要.
- 药物输送方法,剂量策略和化合物配方显著影响治疗疗效和副作用概况.
结论:
- 在PD中治疗药物监测对于提高治疗疗效和实现精准医学至关重要.
- 迫切需要进一步的临床研究来验证TDM在优化PD治疗中的实用性.
- 在帕金森病患者中,TDM可以有助于更好地管理运动和非运动症状.
相关概念视频
01:24Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
01:15Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
01:28Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:19Pharmacovigilance
789
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
789